SmeNSELISTED
ABH Healthcare IPO
₹96 – ₹96 · Issue Size ₹34.98 CrIPO Overview
Business Model
Competitive Advantages
- Doctor led professional management team with proven execution capabilities
- We are led by qualified and experienced management team. Our Promoter and Whole-time Director, Dr. Kamal Baghi, holds
- Dr. Kamal Baghi founded Anil Baghi Hospital in 1985 and was also the founding member of Anil Baghi School of
- Nursing, Genesis Institute of Dental Sciences & Research, a postgraduate dental college and also Anil Baghi College of
- Nursing. He is an active member of the Federation of Indian Chambers of Commerce and Industry (FICCI) Healthcare
- Committee. Further, he was elected as a fellow of I.M.A. Academy of Medical Specialities in cardiology. He has around 4
- (four) decades of experience in the healthcare sector.
IPO Timeline
Listing Performance
Strengths & Weaknesses
Strengths
- Doctor led professional management team with proven execution capabilities
- We are led by qualified and experienced management team. Our Promoter and Whole-time Director, Dr. Kamal Baghi, holds
- Dr. Kamal Baghi founded Anil Baghi Hospital in 1985 and was also the founding member of Anil Baghi School of
- Nursing, Genesis Institute of Dental Sciences & Research, a postgraduate dental college and also Anil Baghi College of
- Nursing. He is an active member of the Federation of Indian Chambers of Commerce and Industry (FICCI) Healthcare
- Committee. Further, he was elected as a fellow of I.M.A. Academy of Medical Specialities in cardiology. He has around 4
- (four) decades of experience in the healthcare sector.
Management & Promoters
K
Kamal BaghiWhole-time Director
F
Foreign CompanyNon -Executive Independent Director
S
Saurabh BaghiManaging Director
V
Vaishali SainiNon-Executive Director
S
Satnam Singh NijjarNon -Executive Independent Director
Y
Yog Raj SainiNon -Executive Independent Director
B
Balwinder SinghNon -Executive Independent Director
Peer Comparison
| Company | P/E | EPS |
|---|---|---|
| ABH Healthcare IPO | — | — |
| Mumbai - Maharashtra India | 57.0x | — |
Pre-IPO Financials
| Period | Revenue (Cr) | PAT (Cr) | Net Worth (Cr) | Total Assets (Cr) |
|---|---|---|---|---|
| December 2024 | ₹0.31 Cr | ₹0.04 Cr | ₹0.31 Cr | — |
| 2015 | ₹20.22 Cr | ₹3.32 Cr | ₹20.22 Cr | — |
| April 2025 | — | ₹1.66 Cr | — | — |
| March 2024 | — | ₹0.71 Cr | — | — |
| September 2024 | — | ₹0.09 Cr | — | — |
About
Q-Line Biotech Ltd. (QBL) is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs since 2013 directly or through its distributor/s majorly to diagnostic service providers, hospitals and medica
| Exchange | NSE |
| Issue Type | sme |
| Face Value | ₹10 per share |
Documents
rupiya.io is for research and education only. IPO data is sourced from public disclosures (DRHP/RHP). Not investment advice. Validate with SEBI-regulated disclosures before acting.